GreenLight Biosciences Holdings
GRNA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $156 | $1,218 | $944 | $944 |
| - Cash | $68 | $31 | $95 | $26 |
| + Debt | $80 | $66 | $19 | $2 |
| Enterprise Value | $168 | $1,253 | $868 | $920 |
| Revenue | $6 | $0 | $1 | $3 |
| % Growth | – | -100% | -67.9% | – |
| Gross Profit | $6 | $0 | $1 | $3 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$154 | -$103 | -$50 | -$28 |
| % Margin | -2,412.1% | – | -5,244% | -921.3% |
| Net Income | -$167 | -$115 | -$54 | -$29 |
| % Margin | -2,616.8% | – | -5,642.3% | -965.2% |
| EPS Diluted | -1.27 | -0.93 | -0.56 | -0.3 |
| % Growth | -36.6% | -66.1% | -86.7% | – |
| Operating Cash Flow | -$137 | -$92 | -$47 | -$26 |
| Capital Expenditures | -$27 | -$15 | -$10 | -$2 |
| Free Cash Flow | -$163 | -$107 | -$57 | -$28 |